Legislative Initiatives and Review of Abuse-Deterrent Opioid Formulations

被引:0
|
作者
Ng, Kimberly Erin [1 ]
Ahmed, Ebtesam [1 ]
Saad, Maha [1 ]
机构
[1] St Johns Univ, Coll Pharm & Hlth Sci, Queens, NY 11439 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Opioid analgesics are the mainstay treatment of moderate-to-severe pain. However, opioids carry a risk of misuse, abuse, and death, and recently have become a public health challenge. In response to the steady increase in opioid abuse, pressure has been growing on pharmaceutical companies to develop prescription opioid formulations that help deter abuse while remaining readily accessible for pain management. This article discusses some of the novel abuse-deterrent formulation methods, including aversion, physical barrier, and agonist-antagonist. It also addresses some of the legislative initiatives and the role of pharmacists in providing education to health care professionals and patients as well as increasing their awareness of prescription opioid misuse and abuse.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 50 条
  • [1] Abuse-Deterrent Opioid Formulations
    Abramowicz, Mark
    Zuccotti, Gianna
    Pflomm, Jean-Marie
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (16): : 1744 - 1745
  • [2] Abuse-deterrent Opioid Formulations
    Litman, Ronald S.
    Pagan, Olivia H.
    Cicero, Theodore J.
    ANESTHESIOLOGY, 2018, 128 (05) : 1015 - 1026
  • [3] Abuse-Deterrent Opioid Formulations
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1476): : 119 - 121
  • [4] Abuse-Deterrent Opioid Formulations #329
    O'Neill, Ryann
    Lor, Kimberly
    Pruskowski, Jennifer
    JOURNAL OF PALLIATIVE MEDICINE, 2017, 20 (06) : 676 - 678
  • [5] Review of Opioid Abuse-Deterrent Formulations: Impact and Barriers to Access
    Webster, Lynn
    Gudin, Jeffrey
    JOURNAL OF PAIN RESEARCH, 2024, 17 : 1989 - 2000
  • [6] Abuse-deterrent opioid formulations: Are they a pipe dream?
    Katz N.
    Current Rheumatology Reports, 2008, 10 (1) : 11 - 18
  • [7] The role of abuse-deterrent formulations in countering opioid misuse and abuse
    Nguyen, V.
    Raffa, R. B.
    Taylor, R.
    Pergolizzi, J. V., Jr.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (06) : 629 - 634
  • [8] Are abuse-deterrent opioid formulations all they are crushed up to be?
    Nelson, Lewis S.
    ADDICTION, 2019, 114 (03) : 401 - 402
  • [9] Effectiveness and framing of pharmaceutical opioid abuse-deterrent formulations
    Peacock, Amy
    Larance, Briony
    Bruno, Raimondo
    Pearson, Sallie-Anne
    Buckley, Nicholas A.
    Farrell, Michael
    Degenhardt, Louisa
    ADDICTION, 2019, 114 (03) : 404 - 405
  • [10] Challenges in the development of prescription opioid abuse-deterrent formulations
    Katz, Nathaniel P.
    Adams, Edgar H.
    Chilcoat, Howard
    Colucci, Robert D.
    Comer, Sandra D.
    Goliber, Philip
    Grudzinskas, Charles
    Jasinski, Donald
    Lande, Stephen D.
    Passik, Steven D.
    Schnoll, Sidney H.
    Sellers, Edward
    Travers, Debra
    Weiss, Roger
    CLINICAL JOURNAL OF PAIN, 2007, 23 (08): : 648 - 660